Half Moon Bay, CA · Health Care · Form D filed Aug 12, 2026
Claris Biotherapeutics, Inc. raised $55.7M
Claris Biotherapeutics, Inc. is a biotechnology company based in Half Moon Bay, California. In an amended Form D filed with the SEC on August 12, 2026, it reported raising $55,737,646 from 14 investors as part of an offering of up to $121,477,910. The first sale in the offering took place on November 25, 2025.
- 6th Form D since 2020. Earlier new notices: Aug 7, 2026 · Sep 22, 2025 · Mar 7, 2025 · Jan 8, 2024 · Apr 27, 2020. All filings on EDGAR
- Still raising. $65.7M of the $121M offering was still unsold at filing.
$116M raised since 2020
5 Form D offerings, as reported to the SEC, the first in Apr 27, 2020. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 7, 2026 | $55.7M | $121M | 14 |
| Sep 22, 2025 | $2.3M | $2.3M | 6 |
| Mar 7, 2025 | $3.3M | $3.3M | 6 |
| Jan 8, 2024 | $10M | $10M | 3 |
| Apr 27, 2020 | $44.5M | $44.5M | 6 |
Lead score
28 out of 100
still raising budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $55,737,646
- Offering size
- $121,477,910
- Investors so far
- 14
- First sale
- November 25, 2025
- Securities offered
- Equity, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Half Moon Bay, California
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D/A (amendment) | $55,737,646 | $121,477,910 | 14 | SEC filing | |
| D (new notice) | $55,737,646 | $121,477,910 | 14 | SEC filing |
Figures come from the company's own filings with the SEC and are shown as reported. The first notice for this offering was filed on August 7, 2026. How to read a Form D.
Updated · Raises in the week of Aug 3, 2026 · Health Care funding in California · August 2026 funding report
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
Tempest Therapeutics, Inc.
Brisbane, CA · filed Oct 145th Form D since 2013
Renue Life Sciences, Inc.
San Carlos, CA · filed Oct 14First Form DStill raising
iPill Inc.
Rowland Heights, CA · filed Oct 132nd Form D since 2025Still raising
White Eagle Sonic Technologies, Inc.
Santa Clara, CA · filed Oct 135th Form D since 2012Still raising
Digestive Disease Center, L.P.
Laguna Hills, CA · filed Oct 83rd Form D since 2022
Lionheart Health, Inc.
Huntington Beach, CA · filed Oct 7First Form DStill raising